Koninklijke Philips (PHG)
(Delayed Data from NYSE)
$21.07 USD
+0.35 (1.69%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $21.08 +0.01 (0.05%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PHG 21.07 +0.35(1.69%)
Will PHG be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PHG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHG
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
PHG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Philips (PHG) Agrees to a Consent Decree With DOJ and FDA
Philips (PHG) Boosts Patient Monitoring With smartQare Deal
Philips (PHG) Expands Sonicare Portfolio With Latest Launch
Other News for PHG
Pharming Group’s Strategic Financial Maneuver
Artisan International Value Fund Q1 2024 Commentary
Pharming Group Lauded for Rare Disease Treatment
Bullish Two Hundred Day Moving Average Cross - PHG
Philips warning letter could lead to pullback in shares, says Jefferies